Testing effectiveness (Phase 2)Study completedNCT00885833
What this trial is testing
Study of Reduced Toxicity Myeloablative Conditioning Regimen for Wiskott-Aldrich Syndrome (WAS)
Who this might be right for
Wiskott-Aldrich Syndrome
The Korean Society of Pediatric Hematology Oncology 5